Cyclooxygenase-2 overexpression is associated with clinical outcome in biliary atresia

European Journal of Pediatric Surgery

Volumn 20, Issue 3, 2010, Pages 164-168

  Honsawek, S ^a   Klaikeaw, N ^a   Vejchapipat, P ^a   Chongsrisawat, V ^a   Ruangvejvorachai, P ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

biliary atresia; clinical outcome; cyclooxygenase 2; jaundice

Indexed keywords

CYCLOOXYGENASE 2;

ARTICLE; BILE DUCT ATRESIA; CLINICAL ARTICLE; COMMON BILE DUCT CYST; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; INTESTINE EPITHELIUM; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; PORTOENTEROSTOMY; BIOSYNTHESIS; EPITHELIUM; METABOLISM;

BILIARY ATRESIA; CYCLOOXYGENASE 2; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE;

EID: 77957284839     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1243628     Document Type: Article

References (24)

1. A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, etal. Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 2003 15 447
2. Balistreri WF, Grand R, Hoofnagle JH, etal. Biliary atresia: current concepts and research directions. Hepatology 1996 23 1682-1692
3. Chayanupatkul M, Honsawek S, Vejchapipat P, etal. Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia. Eur J Pediatr Surg 2009 19 246-250
4. Cheng AS, Chan HL, Leung NW, etal. Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy. Aliment Pharmacol Ther 2002 16 251-260
5. Cheng J, Imanishi H, Iijima H, etal. Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis. Hepatol Res 2002 23 185-195
6. Davenport M. Biliary atresia. Semin Pediatr Surg 2005 14 42-48
7. Davenport M, Gonde C, Redkar R, etal. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 2001 36 1017-1025
8. DuBois RN, Abramson SB, Cofford L, etal. Cyclooxygenase in biology and disease. FASEB J 1998 12 1063-1073
9. El-Bassiouny AE, Zoheiry MM, Nosseir MM, etal. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma. Med Gen Med 2007 9 45
10. Hla T, Bishop-Bailey D, Liu CH, etal. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 1999 31 551-557
11. Honsawek S, Chongsrisawat V, Vejchapipat P, etal. Elevation of serum stem-cell factor in postoperative biliary atresia. Pediatr Int 2007 49 888-893
12. Honsawek S, Chongsrisawat V, Vejchapipat P, etal. Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 2005 21 73-77
13. Hui AY, Leung WK, Chan HL, etal. Effect of celecoxib on experimental liver fibrosis in rat. Liver Int 2006 26 125-136
14. Kim SM, Park KC, Kim HG, etal. Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts. Hepatol Res 2008 38 800-809
15. Koga H, Sakisaka S, Ohishi M, etal. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 1999 29 688-696
16. Liu C, Chiu JH, Chin T, etal. Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury. J Pediatr Surg 2000 35 1591-1596
17. Mohammed NA, Abd El-Aleem SA, El-Hafiz HA, etal. Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis. J Clin Pathol 2004 57 350-354
18. Morinaga S, Yamamoto Y, Noguchi Y, etal. Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma. J Gastroenterol Hepatol 2002 17 1110-1116
19. Pazirandeh S, Khettry U, Gordon FD, etal. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States. Dig Dis Sci 2007 52 220-227
20. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996 271 33157-33160
21. Vejchapipat P, Theamboonlers A, Poomsawat S, etal. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia. Eur J Pediatr Surg 2008 18 415-418
22. Vejchapipat P, Poomsawat S, Imvised T, etal. Overexpression of hepatic inducible nitric oxide synthase in biliary atresia. Hepatol Res 2008 38 1018-1025
23. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996 270 G393-G400
24. Yu J, Hui AY, Chu ES, etal. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats. Liver Int 2009 29 25-36